Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double-Blind, Randomized, Crossover Trial-Reference-Cited by-同舟云学术

Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double-Blind, Randomized, Crossover Trial

Published:2019-05 Issue:9 Volume:199 Page:1086-1096
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Vogel-Claussen Jens¹²^ORCID,Schönfeld Christian-Olaf¹²,Kaireit Till F.¹²,Voskrebenzev Andreas¹²,Czerner Christoph P.¹²,Renne Julius¹²,Tillmann Hanns-Christian³,Berschneider Korbinian⁴,Hiltl Simone⁴,Bauersachs Johann⁵,Welte Tobias⁶²,Hohlfeld Jens M.⁶²⁷

Affiliation:

1. Institute for Diagnostic and Interventional Radiology

2. German Center for Lung Research (BREATH), Hannover, Germany

3. Novartis Institutes for Biomedical Research, Basel, Switzerland

4. Novartis Pharma GmbH, Clinical Research Respiratory, Nuremberg, Germany; and

5. Department of Cardiology and Angiology, and

6. Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany

7. Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine